跳至主要内容
临床试验/CTRI/2021/01/030176
CTRI/2021/01/030176尚未招募不适用

A Clinical Study Of Takradhara And Trivrutadi Choorna Virechana In Madhumeha W.S.R. To Diabetes Mellitus

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年6月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To Improvement In Subjective And Objective Parameters.Find Out The Comparative Efficacy Of The Treatment In Both The Group

研究概览

简要总结

Madhumeha  is vatic disease caused by excess intake of guru - snigdh food , aml - lavan ras ,too much sleeping ,too much rest , lack of exercise ,lack of vaman - virechana by the patients of madhumeha rog as acharya charak has mentioned in its pathogenesis.

Type -2 Diabetes Mellitus is due to insulin [hormone ] resistance . So the body is unable to use insulin .about 90% of diabetic patients have Type -2 Diabetes Mellitus.

It usually occurs after 40 years .

This study is open labelled parallel group trial  of 30 patients  to prove the efficacy of takradhara and trivrutadi choorna virechana in the management of madhumeh rog .  

in which 15 patients of diabetes will be given trivrutadi choorna virechana  for  2 times within 45 days.

other 15 patients of  diabetes will be given takradhara for 21 days in 2  step. each step having 10 days and  these 2 steps  having gap of 10 days. In this gap  there is no procedure .

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • confirmed case of diabetes mellitus type 2 on the basis of laboratory investigation and observed sign and symptoms patients having FBS level range between 110-200 mg/dl and PPBS between 140 -250 mg/dl will be selected for the study glycosylated hemoglobin range < 7%.

排除标准

  • type 1 diabetes mellitus,
  • insulin dependent
  • gestational diabetes
  • having any other systemic disease.

结局指标

主要结局

To Improvement In Subjective And Objective Parameters.Find Out The Comparative Efficacy Of The Treatment In Both The Group

时间窗: 45 Days

次要结局

  • To Find Out The Comparative Efficacy Of The Treatment In Both The Group(45 Days)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验